S23 is a selective androgen receptor modulator (SARM) that has been studied in preclinical and animal models for its potential effects on muscle growth and other androgenic effects. Like other SARMs, S23 was initially developed to address conditions like muscle wasting and osteoporosis, but it is not approved for human use by regulatory agencies such as the FDA.
Here are some of the potential effects and actions associated with S23:
Muscle Growth: S23 is believed to bind to androgen receptors in muscle tissues, which can increase protein synthesis. This action may lead to muscle growth, similar to the effects of traditional anabolic steroids.
Improved Strength: Users have reported increased strength while using S23, which can be beneficial for athletes and bodybuilders looking to enhance their performance.
Fat Loss: Some users have suggested that S23 may promote fat loss and a reduction in body fat. This effect could be due to the increase in muscle mass, which can boost metabolic rate and contribute to fat burning.
Androgenic Effects: S23, like other androgens, may have androgenic effects, which can include changes in sexual function, libido, and potentially virilization (masculinization) in women.
Bone Health: S23 may have positive effects on bone health and density, similar to traditional androgens, which could be beneficial for individuals with osteoporosis or other bone-related conditions.
It's important to note that while S23 has shown promising results in animal studies, its long-term safety and efficacy in humans are not well-established. Additionally, S23, like other SARMs, may have potential side effects and risks, including hormonal imbalances, cardiovascular issues, liver toxicity, and other androgen-related side effects.
